Table 2.
HRs for incident diabetes by treatment arm and genotype at ENPP1K121Q
Group | Basic model HR (95% CI) | P | Model with race/ethnicity HR (95% CI) | P | Model with race/ethnicity + BMI HR (95% CI) | P |
---|---|---|---|---|---|---|
Placebo | 1.38 (1.08–1.76) | 0.01 | 1.38 (1.04–1.83) | 0.03 | 1.36 (1.02–1.80) | 0.04 |
Metformin | 1.08 (0.81–1.43) | 0.60 | 1.10 (0.79–1.54) | 0.57 | 1.09 (0.78–1.53) | 0.60 |
Lifestyle | 0.89 (0.63–1.25) | 0.51 | 0.81 (0.55–1.21) | 0.31 | 0.83 (0.56–1.24) | 0.37 |
Estimates of HR are from a dominant genetic model (Q/X vs. K/K). All models are adjusted for age and sex. The interaction between treatment group and rs1044498 was nominally significant with P = 0.03.